TY  - JOUR
AU  - Vink, Peter
AU  - Ramon Torrell, Josep Maria
AU  - Sanchez Fructuoso, Ana
AU  - Kim, Sung-Joo
AU  - Kim, Sang-Il
AU  - Zaltzman, Jeff
AU  - Ortiz, Fernanda
AU  - Campistol Plana, Josep Maria
AU  - Fernandez Rodriguez, Ana Maria
AU  - Rebollo Rodrigo, Henar
AU  - Campins Marti, Magda
AU  - Perez, Rafael
AU  - González Roncero, Francisco Manuel
AU  - Kumar, Deepali
AU  - Chiang, Yang-Jen
AU  - Doucette, Karen
AU  - Pipeleers, Lissa
AU  - Agüera Morales, Maria Luisa
AU  - Rodriguez-Ferrero, Maria Luisa
AU  - Secchi, Antonio
AU  - McNeil, Shelly A
AU  - Campora, Laura
AU  - Di Paolo, Emmanuel
AU  - El Idrissi, Mohamed
AU  - López-Fauqued, Marta
AU  - Salaun, Bruno
AU  - Heineman, Thomas C
AU  - Oostvogels, Lidia
AU  - Z-041 Study Group
PY  - 2020
DO  - 10.1093/cid/ciz177
UR  - http://hdl.handle.net/10668/13670
T2  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
AB  - The incidence of herpes zoster is up to 9 times higher in immunosuppressed solid organ transplant recipients than in the general population. We investigated the immunogenicity and safety of an adjuvanted recombinant zoster vaccine (RZV) in renal...
LA  - en
KW  - herpes zoster vaccine
KW  - immunogenicity
KW  - immunosuppression
KW  - renal transplant
KW  - safety
KW  - Adult
KW  - Antibodies, Viral
KW  - Herpes Zoster
KW  - Herpes Zoster Vaccine
KW  - Herpesvirus 3, Human
KW  - Humans
KW  - Immunogenicity, Vaccine
KW  - Kidney Transplantation
KW  - Vaccines, Synthetic
TI  - Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
TY  - research article
VL  - 70
ER  -